跳至主要内容
临床试验/NCT05594810
NCT05594810终止不适用

The Feasibility and Potential Efficacy of Adding Tobacco Treatment Using EMDR (ToTEM) to a Regular Smoking Cessation Program A Pilot Randomized Controlled Trail in Inpatient Daily Smokers With a Substance Use Disorder

IrisZorg2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2023年2月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
3
试验地点
2
主要终点
Retention of participants

研究概览

简要总结

Rationale: It is well established that tobacco use has severe health consequences. The prevalence of Tobacco Use Disorder (TUD) is among the highest in populations with Substance Use Disorders (SUD). Despite behavioral and pharmacological treatment options, relapse rates remain high. Therefore, there is a need for additional smoking cessation treatment options that aid long-term abstinence.

A potential interesting intervention is addiction-focused Eye Movement Desensitization and Reprocessing (AF-EMDR) therapy. However, the limited research on AF-EMDR therapy and mixed findings thus far prohibit clinical use. Recently, on the basis of diverse findings thus far, an adjusted AF-EMDR protocol has been developed.

详细描述

SUMMARY

Rationale: It is well established that tobacco use has severe health consequences. The prevalence of Tobacco Use Disorder (TUD) is among the highest in populations with Substance Use Disorders (SUD). Despite behavioral and pharmacological treatment options, relapse rates remain high. Therefore, there is a need for additional smoking cessation treatment options that aid long-term abstinence.

A potential interesting intervention is addiction-focused Eye Movement Desensitization and Reprocessing (AF-EMDR) therapy. However, the limited research on AF-EMDR therapy and mixed findings thus far prohibit clinical use. Recently, on the basis of diverse findings thus far, an adjusted AF-EMDR protocol has been developed.

Objective: to investigate areas of uncertainty about a possible future definitive RCT using AF-EMDR as an add-on intervention to a Smoking Cessation Program (SCP), by determining:

  • Feasibility/process outcomes (e.g. recruitment, adherence, treatment fidelity).
  • Preliminary clinical efficacy in order to estimate the effect size for a future power analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Tobacco Use Disorder according to the DSM-5 (American Psychiatric Association, 2013) criteria.
  • Age ≥ 18 years.
  • Good Dutch language proficiency (based on clinical judgement).
  • Smoking, on average, ≥ 10 cigarettes per day pre-admission.
  • A score of at least 5 on a scale from 0 to 10, for motivation and self-efficacy
  • A planned inpatient stay of ≥ 4 weeks.
  • Written informed consent.

排除标准

  • Serious therapy interfering behavior or symptoms that also interfere with TAU, based on clinical judgement (e. g. psychiatric or medical crisis that requires immediate intervention).

结局指标

主要结局

Retention of participants

时间窗: 1 year

The retention of participants from randomization until the last follow-up.

Acceptability in terms of compliance

时间窗: 1 year

The acceptability of AF-EMDR to participants in terms of compliance, measured by the total number of sessions attended and the proportion of attended versus non attended (planned) sessions; a higher proportion of attended sessions reflects better compliance.

Acceptability in terms of adherence

时间窗: 1 year

The acceptability of AF-EMDR to therapists in terms of adherence to the protocol, measured by the score of an independent rater on a self-developed, a-priori established adherence rating protocol using 47 Likert-type items (range 1-5); a higher score reflects better adherence.

次要结局

  • Proportion of participants(1 year)
  • The feasibility of the outcome measures(1 year)
  • Missing data(1 year)

研究者

发起方
IrisZorg
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验